POLIVY

NDC 50242-103 · Genentech, Inc.

Generic namepolatuzumab vedotin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)POLATUZUMAB VEDOTIN

Strength30 mg/1.88mL

Marketing categoryBLA

Packages

50242-103-01 — 1 VIAL in 1 CARTON (50242-103-01) / 6 mL in 1 VIAL

J9309 — Injection, polatuzumab vedotin-piiq, 1 mg Medicare Part B payment limit (ASP + 6%): $143.61

FDA lists these products with the same active ingredient.

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.